Moderna Inc【MRNA】株式ニュース

	リアルタイム株価	レベル2
Forex

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma PR...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at...

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program, as the third Phase 3 trial for the...

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and...

Form 4 - Statement of changes in beneficial ownership of securities

Shareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA

Shareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

axelvento 4日前

NEXT> Why a teenager’s bird-flu infection is ringing alarm bells for scientists

https://www.nature.com/articles/d41586-024-03805-4

👀 1 👍️ 1

axelvento 6日前

Johns Hopkins surgeon Makary is Trump’s pick to lead FDA "pro-vaccine"

https://www.healthcaredive.com/news/trump-fda-martin-makary-surgeon-nominate/733829/

👌 2 👍️ 1

reyprimero 1週前

Mrna undervalued a lot, time to load the truck, IMO

👍️ 2 💯 3

Vexari 1週前

Manipulation is key

To the equation

👎️ 1 🗑️ 1 🚽 1 🤪 1 ⤵️ 1

axelvento 1週前

Our question is, what data is Mr. Kennedy talking about? Comprehensive national vaccine safety data are readily available to anyone. This includes the safety data used to license vaccines and data gathered after they have gone into use

https://www.nytimes.com/2024/11/20/opinion/rfk-jr-vaccines-public-health.html

$MRNA

👍️ 2 😄 1

axelvento 2週前

HSBC upgrades to Buy on underestimated pipeline potential

👍️ 2 🤙 1

axelvento 2週前

Trump gives RFK Jr McDonald’s ‘poison’ to eat on private plane

https://www.yahoo.com/news/trump-gives-rfk-jr-mcdonald-133657991.html

👍️ 1 😴 1 🤣 1

axelvento 2週前

Bears need to take into consideration the CMV data coming our this quarter. It's a 3-5 TAM drug with no competitors
I'd be careful shorting this right now!

Kennedy’s spokesperson did not respond to my request for comment last night as to whether, as HHS secretary, RFK Jr. would move to outlaw any existing vaccines, and referred me to his victory-lap post on X, which did not mention the topic

https://www.theatlantic.com/politics/archive/2024/11/trump-health-human-services-nomination/680674/

clown-

He won't be confirmed by the Senate, in my opinion.

👍️ 2 🙏 1 🤞 1

Stock Guy777 2週前

By the looks of the chart it has been finished! This thing was well into the 300s when I traded it from $80’s to 300+ and now look at it!! Look Out below! Just decided to come back and take a look. It’s obviously done horrible as did the” Shot”

👍️ 1

Bountiful_Harvest 2週前

Vaccine Stocks Slide Further After Trump Taps RFK Jr. To Lead HHS; CNN Outraged

https://www.zerohedge.com/markets/vaccine-stocks-slide-further-after-trump-taps-rfk-jr-lead-hhs

Moderna is finished...

👍️ 1

Stock Guy777 2週前

Yeah, good for you. I played this back in the day. And got out. I was never a fan, just knew before the actual vaccine was created, that it would run up.

👍️0

Stock Guy777 2週前

Yeah, for the better! Finally stopping these Frankenstein doctors and their controversial “shots” that play havoc on your whole body that I believe potentially killed my father early

👍️ 1

spartex 2週前

Well right now it is having a huge impact on MRNA longs that are deeply under water if they haven't hedged with puts.

A four year low going all the way back to April 2020 period. Brutal. Glad I alerted the troops on this news yesterday to save themselves 7% or more downward draft today!

👍️0

axelvento 2週前

Trump’s latest controversial Cabinet pick could have a huge impact on Americans’ health and lives
https://edition.cnn.com/2024/11/15/politics/trump-rfk-cabinet-pick-american-health-analysis/index.html

the game$$$$$$$

👍️ 1 🤟 1

axelvento 2週前

RFK Jr. has built a reputation as a vaccine skeptic but has stopped short of adopting the “anti-vaxx” label attributed to him by critics. The former environmental lawyer has said his children are vaccinated and that he does not oppose safe vaccines.

relax$

👍️ 1 😃 1

axelvento 2週前

Kennedy has been one of the country’s most prominent anti-vaccine conspiracy theorists for years and has frequently spread falsehoods about the safety and efficacy of vaccines. Last week, Kennedy said he would “immediately” begin studying vaccine safety and efficacy but promised to not “take vaccines away from anybody.”

👍️0

Bountiful_Harvest 2週前

Shares of $MRNA and other hot shot stocks in full collapse on news of RFK joining the Trump admin

👍️0

spartex 2週前

Big selling all of a sudden. Sub $40 now. 52 week low.

Appears that Trump will nominate Rfk Jr. to Health and Human Services Admin.

https://www.politico.com/news/2024/11/14/robert-f-kennedy-jr-trump-hhs-secretary-pick-00188617

😜 1

axelvento 2週前

next-
https://www.theguardian.com/society/2024/oct/23/doctors-trial-worlds-first-vaccine-against-vomiting-bug-norovirus

👍️ 4 🔜 1

Vexari 2週前

The majority shareholder of Moderna is?

When you are suffering

They are profiting

👇️ 1 🗑️ 1 🚽 1 🤪 1 🧻 1

axelvento 3週前

https://www.biospace.com/job-trends/biospace-announces-2025-best-places-to-work-in-biopharma

👋 1 👍 1

axelvento 3週前

Jpmorgan Chase & Co ownership in MRNA / Moderna, Inc.
On November 8, 2024 - Jpmorgan Chase & Co filed a 13F-HR form disclosing ownership of 2,227,044 shares of Moderna, Inc. (US:MRNA) valued at $148,833,351 USD as of September 30, 2024. The entity filed a previous 13F-HR on August 12, 2024 disclosing 1,756,708 shares of Moderna, Inc.. This represents a change in shares of 26.77% during the quarter. The current value of the position is $104,292,471 USD.

https://fintel.io/so/us/mrna/jpmorgan-chase-

👍 2

axelvento 3週前

https://www.acsh.org/news/2024/11/07/dont-be-afraid-mrna-vaccines-49111

👍️ 3 🤙 1

axelvento 3週前

Moderna Buys Norwood Campus for $400M

https://bankerandtradesman.com/moderna-buys-norwood-campus-for-400m/#:~:text=Lab%20developer%20Alexandria%20Real%20Estate,core%20properties%20in%20Greater%20Boston.

👍️ 3 😀 1

axelvento 3週前

Moderna (MRNA) Q3 2024 Earnings Call Transcript

https://www.fool.com/earnings/call-transcripts/2024/11/07/moderna-mrna-q3-2024-earnings-call-transcript/

MRNA is set to report third-quarter 2024 earnings on Nov. 7, before the opening bell. The Zacks Consensus Estimate for sales and earnings is pegged at $1.25 billion and a loss of $1.91 per share, respectively

👍️0

axelvento 1月前

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

https://investors.modernatx.com/news/news-details/2024/Merck-and-Moderna-Initiate-Phase-3-Trial-Evaluating-Adjuvant-V940-mRNA-4157-in-Combination-with-KEYTRUDA-pembrolizumab-After-Neoadjuvant-KEYTRUDA-and-Chemotherapy-in-Patients-With-Certain-Types-of-Non-Small-Cell-Lung-Cancer-NSCLC/default.aspx

huge news$

👍️ 1 🤑 1

axelvento 1月前

https://www.investing.com/news/company-news/piper-sandler-maintains-overweight-rating-on-moderna-stock-93CH-3680972

👋 1 👍️ 2

axelvento 1月前

20B market cap, 10B in cash, high potential pipeline in 4 therapeutic areas!

👍️ 2 💪 1

axelvento 1月前

Moderna has a whopping 33 million short share interest, but daily volume now a paper-thin 3.7 million

"Highest shorted stock on S&P500"

👍️ 1 🤣 1 ☝️ 1

axelvento 1月前

MRNA December 6th Options Begin Trading

https://www.nasdaq.com/articles/mrna-december-6th-options-begin-trading

👍️0

axelvento 1月前

Moderna’s norovirus vaccine enters Phase III trials in the UK
The firm hopes to file marketing applications in 2026 to have the vaccine approved by health regulators.

https://www.clinicaltrialsarena.com/news/modernas-norovirus-vaccine-enters-phase-iii-trials-in-the-uk/

👍️ 2 🤙 1

Vexari 1月前

Depends

On the road

That they're on

👎️ 1 🗑️ 1 🚽 1 🧻 1 0️⃣ 1

Vexari 1月前

All that is marketed

Is fear based

🌬️ 1 🎃 1 👎️ 1 🕳️ 1 🗑️ 1

gapole 1月前

looks like meltdown here. where is the bad news? $53.54

👍️0

Monksdream 1月前

MRNA new 52. Week low

👍️0

axelvento 1月前

Moderna stock touches 52-week low. bouncer

👍️0

axelvento 1月前

https://www.kcl.ac.uk/news/mrna-cancer-vaccine-potential-advanced-stage-cancer-patients-in-phase-1-trial

👍️ 1 ✌️ 1

jondoeuk 1月前

I couldn't find a PR or the poster.

👍️0

Vexari 2月前

Unraveling all the Lies of the Covid-19

Psychological Operation

👎️ 2 🗑️ 1 😎 1 🤥 1 🧻 1 0️⃣ 1

axelvento 2月前

$MRNA We are tackling cancer on an individual basis where we can take samples from each patient, understand their cancer, and design a therapy specifically for them

https://www.fastcompany.com/91202048/the-mrna-advantage

👍️ 1 🫨 1 ☝️ 1

tmonkey 2月前

this one near a bottom-im in------tmonkey

👍️0

axelvento 2月前

https://www.globenewswire.com/news-release/2024/10/04/2958235/0/en/Global-mRNA-Cancer-Vaccine-Clinical-Trial-FDA-Approval-Market-Size-Future-Opportunity-Companies-Insight.html

$MRNA

👍️ 1 🤑 1

axelvento 2月前

Join us on Nov 8, as we, alongside
moderna_
, share promising data on anti-GPC3 in vivo CAR-M therapy for HCC. We'll also present TIP poster for the Ph1 study of anti-HER2 CAR-Monocytes targeting solid tumors.

https://ir.carismatx.com/news-releases/news-release-details/carisma-therapeutics-announces-upcoming-presentations-sitc-2024

👍️ 1 😃 1

axelvento 2月前

back to the 23 November lows bounce spot watching either way to see if holds or breaks.

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Moderna Inc (MRNA)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

MRNA ニュース

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence

Form 4 - Statement of changes in beneficial ownership of securities

Shareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

MRNA Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

BLACK FRIDAY

Forexで最大60%オフ

1年間40％、2年間40％、*3年間60％

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Moderna Inc (MRNA) ニュース

Moderna Inc (MRNA)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

MRNA ニュース

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence

Form 4 - Statement of changes in beneficial ownership of securities

Shareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

MRNA Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

BLACK FRIDAY

Forexで最大60%オフ

1年間40％、2年間40％、*3年間60％